• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

65岁及以上的成年人针对呼吸道合胞病毒融合蛋白的功能性记忆T细胞数量减少。

Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein.

作者信息

Cherukuri Anu, Patton Kathryn, Gasser Robert A, Zuo Fengrong, Woo Jennifer, Esser Mark T, Tang Roderick S

机构信息

Infectious Diseases/Vaccines Research, MedImmune, LLC, Mountain View, California, USA.

出版信息

Clin Vaccine Immunol. 2013 Feb;20(2):239-47. doi: 10.1128/CVI.00580-12. Epub 2012 Dec 12.

DOI:10.1128/CVI.00580-12
PMID:23239796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3571266/
Abstract

Respiratory syncytial virus (RSV) infects elderly (≥65 years) adults, causing medically attended illness and hospitalizations. While RSV neutralizing antibody levels correlate inversely with RSV-associated hospitalization in the elderly, the role of RSV-specific T cells in preventing disease in the elderly remains unclear. We examined RSV-specific humoral, mucosal, and cellular immune profiles in healthy elderly (65 to 85 years) and young (20 to 30 years) adults. RSV neutralization antibody titers in the elderly (10.5 ± 2.2 log(2)) and young (10.5 ± 2.1 log(2)) were similar. In contrast, levels of RSV F protein-specific gamma interferon (IFN-γ)-producing T cells were lower in elderly (180 ± 80 spot-forming cells [SFC]/10(6) peripheral blood mononuclear cells [PBMC]) than in young adults (1,250 ± 420 SFC/10(6) PBMC). Higher levels of interleukin-13 (IL-13; 3,000 ± 1,000 pg/ml) in cultured PBMC supernatants and lower frequency of RSV F-specific CD107a(+) CD8(+) T cells (3.0% ± 1.6% versus 5.0% ± 1.6%) were measured in PBMC from elderly than young adults. These results suggest that deficient RSV F-specific T cell responses contribute to susceptibility to severe RSV disease in elderly adults.

摘要

呼吸道合胞病毒(RSV)感染老年人(≥65岁),导致需要就医的疾病和住院治疗。虽然RSV中和抗体水平与老年人中RSV相关住院率呈负相关,但RSV特异性T细胞在预防老年人疾病中的作用仍不清楚。我们检测了健康老年人(65至85岁)和年轻人(20至30岁)中RSV特异性体液、黏膜和细胞免疫谱。老年人(10.5±2.2 log₂)和年轻人(10.5±2.1 log₂)的RSV中和抗体滴度相似。相比之下,老年人(180±80斑点形成细胞[SFC]/10⁶外周血单个核细胞[PBMC])中产生RSV F蛋白特异性γ干扰素(IFN-γ)的T细胞水平低于年轻人(1250±420 SFC/10⁶ PBMC)。在培养的PBMC上清液中,老年人的白细胞介素-13(IL-13;3000±1000 pg/ml)水平较高,且在PBMC中,老年人RSV F特异性CD107a⁺ CD8⁺ T细胞的频率较低(3.0%±1.6%对5.0%±1.6%)。这些结果表明,RSV F特异性T细胞反应不足导致老年人对严重RSV疾病易感。

相似文献

1
Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein.65岁及以上的成年人针对呼吸道合胞病毒融合蛋白的功能性记忆T细胞数量减少。
Clin Vaccine Immunol. 2013 Feb;20(2):239-47. doi: 10.1128/CVI.00580-12. Epub 2012 Dec 12.
2
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.含有呼吸道合胞病毒F蛋白的病毒样颗粒疫苗通过调节树突状细胞和效应T细胞的特定亚群提供无肺部疾病的保护。
J Virol. 2015 Nov;89(22):11692-705. doi: 10.1128/JVI.02018-15. Epub 2015 Sep 9.
3
A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.一种新型的呼吸道合胞病毒(RSV)F亚基疫苗,佐以GLA-SE,在啮齿动物模型中引发了强大的保护性TH1型体液免疫和细胞免疫。
PLoS One. 2015 Mar 20;10(3):e0119509. doi: 10.1371/journal.pone.0119509. eCollection 2015.
4
Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.与非洲绿猴血液相比,呼吸道合胞病毒在其肺部引发更丰富的CD8 + T淋巴细胞反应。
PLoS One. 2017 Nov 9;12(11):e0187642. doi: 10.1371/journal.pone.0187642. eCollection 2017.
5
Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.黑猩猩腺病毒载体和MVA载体的呼吸道合胞病毒疫苗在成人中安全且具有免疫原性。
Sci Transl Med. 2015 Aug 12;7(300):300ra126. doi: 10.1126/scitranslmed.aac5745.
6
T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells.人外周血单个核细胞对呼吸道合胞病毒融合蛋白和附着蛋白的T细胞应答。
Viral Immunol. 2006 Winter;19(4):669-78. doi: 10.1089/vim.2006.19.669.
7
Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection.预先存在的中和抗体可预防呼吸道合胞病毒感染后 CD8 T 细胞介导的免疫病理。
Mucosal Immunol. 2020 May;13(3):507-517. doi: 10.1038/s41385-019-0243-4. Epub 2019 Dec 16.
8
Enzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.用于检测人呼吸道合胞病毒F蛋白特异性产生γ干扰素的T细胞的酶联免疫斑点测定法。
Clin Vaccine Immunol. 2014 May;21(5):628-35. doi: 10.1128/CVI.00736-13. Epub 2014 Feb 26.
9
T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection.成人在自然呼吸道合胞病毒感染期间的 T 细胞反应。
J Infect Dis. 2018 Jul 2;218(3):418-428. doi: 10.1093/infdis/jiy016.
10
Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.非增殖型、重组水疱性口炎病毒载体编码呼吸道合胞病毒蛋白可产生针对 RSV 的强烈体液和细胞免疫应答,并在小鼠中具有保护作用。
Immunol Lett. 2013 Feb;150(1-2):134-44. doi: 10.1016/j.imlet.2012.12.005. Epub 2012 Dec 20.

引用本文的文献

1
Immunogenicity, safety, and tolerability of a β-glucan-CpG-adjuvanted respiratory syncytial virus vaccine in Japanese healthy participants aged 60 to 80 years: A phase 2, randomized, double-blind, dose-finding study.β-葡聚糖-CpG佐剂呼吸道合胞病毒疫苗在60至80岁日本健康参与者中的免疫原性、安全性和耐受性:一项2期随机双盲剂量探索性研究。
Hum Vaccin Immunother. 2025 Dec;21(1):2489900. doi: 10.1080/21645515.2025.2489900. Epub 2025 Apr 21.
2
The recent landscape of RSV vaccine research.呼吸道合胞病毒疫苗研究的最新概况。
Ther Adv Vaccines Immunother. 2025 Jan 10;13:25151355241310601. doi: 10.1177/25151355241310601. eCollection 2025.
3
The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease.呼吸道合胞病毒(RSV)感染动物模型的建立与增强型 RSV 疾病。
Viruses. 2024 Oct 30;16(11):1701. doi: 10.3390/v16111701.
4
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates.一种自我扩增的 RNA RSV 融合前疫苗在预先暴露和未感染的非人类灵长类动物中引发了强烈的免疫反应。
Nat Commun. 2024 Nov 14;15(1):9884. doi: 10.1038/s41467-024-54289-9.
5
[Vaccination against respiratory syncytial virus (RSV)-For the protection of infants and older adults].[针对呼吸道合胞病毒(RSV)的疫苗接种——用于保护婴儿和老年人]
Inn Med (Heidelb). 2024 Nov;65(11):1066-1075. doi: 10.1007/s00108-024-01795-z. Epub 2024 Oct 25.
6
Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.50-59 岁成年人与≥60 岁老年人相比,呼吸道合胞病毒融合前 F 蛋白疫苗具有非劣效免疫原性和一致安全性。
Clin Infect Dis. 2024 Oct 15;79(4):1074-1084. doi: 10.1093/cid/ciae364.
7
Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial.AS01E 佐剂呼吸道合胞病毒融合前 F 蛋白疫苗在老年人中接种 1 剂后的免疫原性和安全性:一项 3 期试验。
J Infect Dis. 2024 Jul 25;230(1):e102-e110. doi: 10.1093/infdis/jiad546.
8
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.mRNA-1345 RSV 疫苗在老年人中的体液免疫原性。
J Infect Dis. 2024 Nov 15;230(5):e996-e1006. doi: 10.1093/infdis/jiae316.
9
Antibody responses to respiratory syncytial virus: a population-based cross-sectional serological study in Southern China, 2021.2021 年中国南方基于人群的呼吸道合胞病毒血清抗体横断面研究。
Clin Microbiol Infect. 2024 Sep;30(9):1183-1189. doi: 10.1016/j.cmi.2024.06.005. Epub 2024 Jun 7.
10
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.T 细胞比抗体更能预防老年人呼吸道合胞病毒感染引发的症状。
Front Immunol. 2023 Oct 13;14:1260146. doi: 10.3389/fimmu.2023.1260146. eCollection 2023.

本文引用的文献

1
An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.一种佐剂化的呼吸道合胞病毒融合蛋白可在老年 BALB/c 小鼠中诱导保护作用。
Immun Ageing. 2012 Oct 2;9(1):21. doi: 10.1186/1742-4933-9-21.
2
Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.疫苗诱导的 CD8+ T 细胞可预防 BALB/c 小鼠呼吸道合胞病毒 A2 株 19F 诱导的发病机制。
J Virol. 2012 Dec;86(23):13016-24. doi: 10.1128/JVI.01770-12. Epub 2012 Sep 26.
3
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects.健康受试者中 T 细胞介导的免疫应答和效应记忆对呼吸道合胞病毒(RSV)的年龄相关性变化。
Immun Ageing. 2010 Oct 20;7:14. doi: 10.1186/1742-4933-7-14.
4
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.全球儿童因呼吸道合胞病毒导致的急性下呼吸道感染负担:系统评价和荟萃分析。
Lancet. 2010 May 1;375(9725):1545-55. doi: 10.1016/S0140-6736(10)60206-1.
5
Vaccination in the elderly: an immunological perspective.老年人的疫苗接种:免疫学视角
Trends Immunol. 2009 Jul;30(7):351-9. doi: 10.1016/j.it.2009.05.002. Epub 2009 Jun 18.
6
Why does the thymus involute? A selection-based hypothesis.胸腺为何会退化?基于选择的假说。
Trends Immunol. 2009 Jul;30(7):295-300. doi: 10.1016/j.it.2009.04.006. Epub 2009 Jun 18.
7
The burden of respiratory syncytial virus infection in young children.幼儿呼吸道合胞病毒感染的负担
N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877.
8
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.两种呼吸道合胞病毒(RSV)疫苗——无佐剂疫苗或明矾佐剂疫苗——与流感疫苗同时接种于高危老年个体时的安全性和免疫原性比较。
J Infect Dis. 2008 Nov 1;198(9):1317-26. doi: 10.1086/592168.
9
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.肺部免疫与免疫病理学:来自呼吸道合胞病毒的经验教训。
Expert Rev Vaccines. 2008 Oct;7(8):1239-55. doi: 10.1586/14760584.7.8.1239.
10
Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation.社区获得性肺炎成人住院患者的病毒感染:患病率、病原体及临床表现
Chest. 2008 Dec;134(6):1141-1148. doi: 10.1378/chest.08-0888. Epub 2008 Aug 8.